Webinar: Digital Remembrance Work – New Approaches in Reminiscence Therapy

Digital technologies open up new possibilities in therapeutic work with older people – especially in memory work. In the context of life story-oriented conversations, personal memories are to be evoked with the help of images, videos, and objects. This can promote mental activity and increase the well-being of people with memory impairments. Such…

digiDEM Bavaria SPOTLIGHT_08: New Dementia Medications - Treatment with Lecanemab

The new Alzheimer's drug Lecanemab is raising great hopes for people with dementia and their caregivers. But which patient groups and how many affected individuals in Germany meet the criteria for treatment with Lecanemab? This essential question is a significant reason for us to dedicate another issue of our special newsletter to...

Train virtually in a group

Scientists from Canada and the US demonstrated how the physical well-being of people with dementia and people with mild cognitive impairment (MCI) can be improved with the help of technology. Among other things, they identified the various types of interventions from technology-based group exercises for people with dementia or MCI and…

„The heart doesn't go senile“

Most people know Dr. Sarah Straub (38) from numerous performances as a musician throughout Germany. However, she is also a specialist in frontotemporal dementia and a clinical neuropsychologist at Ulm University Hospital. There, she researches people with dementia and their caregivers. As an artist and as a dementia expert, she sees herself as...

Lecanemab: digiDEM Bavaria calculates initial estimates for Germany

The new Alzheimer's drug Lecanemab is raising great hopes for people with dementia and their caregivers. Very recently, a panel of experts from the European Medicines Agency (EMA) recommended the new active ingredient for treatment – subject to strict conditions. But which patient groups meet the requirements for treatment with Lecanemab? This...

digiDEM Bavaria SPOTLIGHT_07: New Medications for Dementia - A „Breakthrough with Side Effects“

In recent weeks, we have informed you in several parts of our special newsletter SCHLAGLICHT – Medications for Dementia about new dementia drugs and challenges in everyday care. You can reread all published issues at any time in our digiDEM Bavaria newsletter archive: https://digidem-bayern.de/newsletter-archiv/. In the seventh and final issue of our special newsletter SCHLAGLICHT – Medications for Dementia, Michael...

Frontotemporal Dementia – A Multifaceted Disease

Demenz ist ein komplexes Krankheitsbild mit vielfältigen Ursachen, von denen die Alzheimer-Erkrankung nur eine Erscheinungsform darstellt. Die frontotemporale Demenz ist die zweithäufigste Demenzform vor dem 65. Lebensjahr. Typische erste Symptome sind Verhaltensauffälligkeiten und/oder Sprachstörungen, die meist schon im mittleren Lebensalter auftreten. Dies stellt das familiäre Umfeld von Menschen mit frontotemporaler …

How fall prevention can succeed

Which factors are associated with falls in people with dementia? Researchers from China investigated this. Their findings provide clear indications of which characteristics to focus on in fall prevention for people with cognitive impairments. While there are numerous studies that examine the risk factors for falls in older individuals...